Jane Street Group LLC acquired a new stake in Cabot Corp (NYSE:CBT) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 4,343 shares of the specialty chemicals company’s stock, valued at approximately $272,000.

Other hedge funds also recently made changes to their positions in the company. Hsbc Holdings PLC increased its stake in shares of Cabot by 1.3% during the third quarter. Hsbc Holdings PLC now owns 98,709 shares of the specialty chemicals company’s stock valued at $6,191,000 after buying an additional 1,222 shares during the period. Bessemer Group Inc. increased its stake in shares of Cabot by 575.7% during the third quarter. Bessemer Group Inc. now owns 2,034 shares of the specialty chemicals company’s stock valued at $128,000 after buying an additional 1,733 shares during the period. Loomis Sayles & Co. L P increased its stake in shares of Cabot by 1.0% during the third quarter. Loomis Sayles & Co. L P now owns 185,290 shares of the specialty chemicals company’s stock valued at $11,621,000 after buying an additional 1,847 shares during the period. Oakbrook Investments LLC increased its stake in shares of Cabot by 32.8% during the third quarter. Oakbrook Investments LLC now owns 7,690 shares of the specialty chemicals company’s stock valued at $482,000 after buying an additional 1,900 shares during the period. Finally, Stone Ridge Asset Management LLC increased its stake in shares of Cabot by 22.8% during the third quarter. Stone Ridge Asset Management LLC now owns 11,799 shares of the specialty chemicals company’s stock valued at $740,000 after buying an additional 2,192 shares during the period. Hedge funds and other institutional investors own 86.38% of the company’s stock.

Shares of CBT stock opened at $46.56 on Friday. The firm has a market capitalization of $2.74 billion, a P/E ratio of 11.55, a PEG ratio of 0.94 and a beta of 1.46. Cabot Corp has a twelve month low of $39.57 and a twelve month high of $68.63. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.92 and a current ratio of 1.46.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, November 5th. The specialty chemicals company reported $1.00 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.09 by ($0.09). Cabot had a positive return on equity of 18.82% and a negative net margin of 3.49%. The firm had revenue of $850.00 million during the quarter, compared to analysts’ expectations of $856.76 million. During the same period in the previous year, the company earned $0.91 earnings per share. Cabot’s revenue for the quarter was up 17.6% on a year-over-year basis. As a group, equities analysts anticipate that Cabot Corp will post 4.59 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 8th. Shareholders of record on Friday, February 22nd will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 2.84%. The ex-dividend date is Thursday, February 21st. Cabot’s dividend payout ratio (DPR) is 32.75%.

Several equities analysts have recently issued reports on the company. Barclays assumed coverage on Cabot in a research note on Monday, October 8th. They set an “overweight” rating and a $76.00 target price on the stock. ValuEngine cut Cabot from a “hold” rating to a “sell” rating in a research note on Thursday, October 11th. Zacks Investment Research cut Cabot from a “buy” rating to a “sell” rating in a research note on Tuesday, October 16th. Loop Capital set a $82.00 price target on Cabot and gave the stock a “buy” rating in a research note on Tuesday, November 6th. Finally, Northcoast Research set a $75.00 price target on Cabot and gave the stock a “buy” rating in a research note on Wednesday, November 7th. Two analysts have rated the stock with a sell rating and five have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $75.33.

WARNING: This story was published by Daily Political and is owned by of Daily Political. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.dailypolitical.com/2019/01/18/jane-street-group-llc-takes-272000-position-in-cabot-corp-cbt.html.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.

See Also: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corp (NYSE:CBT).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.